Integrated BioPharma Inc (INBP)

Consumer Defensive | Packaged Foods
Income Statement (Quarterly) 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Revenue 13,947,000 12,614,000 13,617,000 12,746,000
Cost of Revenue 12,396,000 11,443,000 12,246,000 11,462,000
Gross Profit 1,551,000 1,171,000 1,371,000 1,284,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 812,000 969,000 881,000 882,000
Operating Expenses 812,000 969,000 881,000 882,000
Operating Income 739,000 202,000 490,000 402,000
Interest Expense 0 0 0 0
Income Before Tax 778,000 185,000 504,000 414,000
Income Tax Expense 167,000 69,000 245,000 146,000
Net Income 611,000 116,000 259,000 268,000
Per Share
EPS 0.02 0.00 0.01 0.01
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-09-30 2022-06-30
Revenue 54,353,000 50,317,000 50,672,000 0 56,246,000
Cost of Revenue 48,791,000 46,433,000 46,611,000 0 49,694,000
Gross Profit 5,562,000 3,884,000 4,061,000 0 6,552,000
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 3,542,000 3,633,000 3,941,000 0 3,807,000
Operating Expenses 3,542,000 3,633,000 3,941,000 0 3,807,000
Operating Income 2,020,000 251,000 120,000 0 1,966,000
Interest Expense 46,000 0 40,000 0 107,000
Income Before Tax 2,062,000 268,000 100,000 0 2,597,000
Income Tax Expense 1,254,000 156,000 134,000 0 -1,241,000
Net Income 808,000 112,000 -34,000 0 3,838,000
Per Share
EPS 0.03 0.00 0.00 0.00 0.13
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Assets
Cash and Cash Equivalents 3,615,000 1,677,000 1,316,000 331,000
Short Term Investments 0 0 0 12,000
Net Receivables 5,430,000 4,668,000 4,511,000 4,888,000
Inventory 9,362,000 11,244,000 10,261,000 11,055,000
Total Current Assets 18,763,000 17,875,000 16,372,000 16,626,000
Property Plant Equipment 2,749,000 3,675,000 4,276,000 3,777,000
Goodwill and Intangibles 0 0 0 0
Total Assets 24,901,000 26,207,000 25,431,000 25,250,000
Liabilities
Account Payables 2,267,000 2,510,000 2,266,000 3,209,000
Short Term Debt 679,000 1,904,000 1,860,000 643,000
Total Current Liabilities 4,248,000 6,123,000 4,828,000 5,263,000
Long Term Debt 672,000 846,000 1,742,000 1,412,000
Total Liabilities 4,584,000 6,969,000 6,570,000 6,675,000
Shareholders Equity
Retained Earnings -31,419,000 -32,227,000 -32,339,000 -32,305,000
Total Shareholders Equity 20,317,000 19,238,000 18,861,000 18,575,000
Balance Sheet (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Assets
Cash and Cash Equivalents 3,615,000 1,677,000 1,316,000 331,000 210,000
Short Term Investments 0 0 0 12,000 0
Net Receivables 5,430,000 4,668,000 4,511,000 4,888,000 5,776,000
Inventory 9,362,000 11,244,000 10,261,000 11,055,000 11,695,000
Total Current Assets 18,763,000 17,875,000 16,372,000 16,626,000 17,998,000
Property Plant Equipment 2,749,000 3,675,000 4,276,000 3,777,000 4,107,000
Goodwill and Intangibles 0 0 0 0 0
Total Assets 24,901,000 26,207,000 25,431,000 25,250,000 25,440,000
Liabilities
Account Payables 2,267,000 2,510,000 2,266,000 3,209,000 3,496,000
Short Term Debt 679,000 1,904,000 1,860,000 643,000 4,130,000
Total Current Liabilities 4,248,000 6,123,000 4,828,000 5,263,000 9,236,000
Long Term Debt 672,000 846,000 1,742,000 1,412,000 1,870,000
Total Liabilities 4,584,000 6,969,000 6,570,000 6,675,000 11,106,000
Shareholders Equity
Retained Earnings -31,419,000 -32,227,000 -32,339,000 -32,305,000 -36,143,000
Total Shareholders Equity 20,317,000 19,238,000 18,861,000 18,575,000 14,334,000
Cash Flow Statement (Quarterly) 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Operating Activities
Net Income 808,000 112,000 -34,000 3,838,000
Depreciation & Amortization 951,000 1,221,000 1,154,000 834,000
Stock Based Compensation 185,000 252,000 320,000 369,000
Change in Working Capital -1,502,000 -744,000 -302,000 565,000
Operating Cash Flow 2,065,000 943,000 1,232,000 4,091,000
Investing Activities
Capital Expenditure -191,000 -553,000 -116,000 -486,000
Investments -191,000 -553,000 -116,000 -486,000
Investing Cash Flow -205,000 -553,000 -111,000 -465,000
Financing Activities
Debt Repayment -8,000 -42,000 -136,000 -58,157,000
Common Stock Issued/Repurchased 86,000 13,000 4,000 34,000
Dividends Paid 0 0 0 0
Financing Cash Flow 78,000 -29,000 -136,000 -3,505,000
Summary
Free Cash Flow 1,874,000 390,000 1,116,000 3,605,000
Net Change in Cash 1,938,000 361,000 985,000 121,000
Cash Flow Statement (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Operating Activities
Net Income 808,000 112,000 -34,000 3,838,000 8,013,000
Depreciation & Amortization 951,000 1,221,000 1,154,000 834,000 826,000
Stock Based Compensation 185,000 252,000 320,000 369,000 231,000
Change in Working Capital -1,502,000 -744,000 -302,000 565,000 -3,046,000
Operating Cash Flow 2,065,000 943,000 1,232,000 4,091,000 3,050,000
Investing Activities
Capital Expenditure -191,000 -553,000 -116,000 -486,000 -295,000
Investments -191,000 -553,000 -116,000 -486,000 -295,000
Investing Cash Flow -205,000 -553,000 -111,000 -465,000 -199,000
Financing Activities
Debt Repayment -8,000 -42,000 -136,000 -58,157,000 -60,728,000
Common Stock Issued/Repurchased 86,000 13,000 4,000 34,000 0
Dividends Paid 0 0 0 0 0
Financing Cash Flow 78,000 -29,000 -136,000 -3,505,000 -3,043,000
Summary
Free Cash Flow 1,874,000 390,000 1,116,000 3,605,000 2,755,000
Net Change in Cash 1,938,000 361,000 985,000 121,000 -192,000